We demonstrated decreased CRF mRNA levels (Fig. 5d), nonsignificantly decreased GR gene expression levels (Fig. 5e; p = 0.0512), and increased MR gene in PD patients (Fig. 5f). This evidence concerns the gene CRH and Parkinson disease.